The Olinde Firm - New Orleans Attorneys
  • Attorneys & Staff
    • Fred Olinde
    • Beth Hagan
  • Defective Drugs
    • Belviq
    • Elmiron
    • Onglyza & Kombiglyze
    • Paraquat
    • Risperdal & Invega Gynecomastia
    • Taxotere
    • Zantac
  • Defective Medical Devices
    • 3M Combat Earplugs
    • Allergan BIOCELL Textured Breast Implant
    • Hernia Mesh
      • Bard® Hernia Mesh
      • Atrium C-Qur Mesh
      • Ethicon Physiomesh
    • Paragard IUD Birth Control Device
  • Personal Injury
    • Car Accident Injuries
    • Nursing Home Injuries
    • Truck Accident Injuries
    • Wrongful Death Cases
  • Blog
  • Contact
Select Page
FDA Issues Safety Announcement For Popular Antibacterial Medication

FDA Issues Safety Announcement For Popular Antibacterial Medication

Aug 10, 2016 | Defective Drugs, Defective Products, Drug Side Effects, Personal Injury, Pharmaceutical Litigation, Product Liability

On July 26, 2016, the Food and Drug Administration (FDA) issued a Safety Announcement for antibacterial drugs containing fluoroquinolone. This includes popularly prescribed antibacterial drugs (and their generic brands) including: Avelox Cipro Cipro Extended-Release...

FREE CASE REVIEW

  • This field is for validation purposes and should be left unchanged.

Recent Posts

  • Paragard Class Action Lawsuit Update August 3, 2023
  • Personal Injury Claims: Traumatic Brain Injury  July 27, 2023
  • Negligent Truckers: Common Causes of Accidents  July 20, 2023
  • Identifying Pain and Suffering Damages After a Louisiana Auto Accident  July 13, 2023
  • C.R. Bard Hernia Mesh Lawsuit Updates July 6, 2023